Treatment of Atopic dermatitis in children by using Kukkiladhi chooranam and Milagu ennai

An Open Clinical trial to evaluate the effectiveness of Kukkiladhi chooranam (Internal medicine) and Milagu ennai (External medicine) in the management of Karappan (Atopic dermatitis) in children among outpatients attending Ayothidoss Pandithar Hospital, National Institute of Siddha - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084915

Enrollment

Registered

2025-04-16

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: Kukkiladhi chooranam (Internal medicine) Milagu ennai (External medicine): Internal medicine: 1.Kukkiladhi chooranam Dosage: Mooviral alavu(800-1000 mg) 3-5 years:300 mg,Bd 6-8 years:40

Eligibility

Inclusion criteria

Inclusion criteria: Children of both sex in the age group of 3 to 12 years with symptoms according to EASI Score: 1.Erythema 2.Oedema 3.Oozing 4.Itching 5.Crusting 6.Scaling 7.Lichenified plaques

Exclusion criteria

Exclusion criteria: 1.K/C/O Scabies 2.K/C/O Contact dermatitis 3.K/C/O Seborrheic Dermatitis 4.K/C/O Psoriasis 5.K/C/O Secondary Bacterial Infections 6.K/C/O Furunculosis 7.K/C/O Neurodermatitis 8.Any other serious illness

Design outcomes

Primary

Measure	Time frame
Effectiveness of the trial drug will be measured by using EASI score before and after treatmentTimepoint: 48 days	—

Secondary

Measure	Time frame
1.The characteristics of the trial drug Kukkiladhi chooranam will be analysed as per PLIM guidelines 2.The characteristics of the trial drug Milagu ennai will be analysed as per PLIM guidelinesTimepoint: 1 month	—

Countries

India

Contacts

Public ContactDr M Meenakshi Sundaram

National Institute of Siddha

mmssiddha@rediffmail.com9444214582

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026